Connect with us

Hi, what are you looking for?

The Smart Citizen Report


Biden to unveil new U.S. drug addiction and overdose strategy

(C) Reuters. U.S. President Joe Biden delivers remarks on infrastructure projects at the Portsmouth Port Authority in Portsmouth, New Hampshire, U.S. April 19, 2022. REUTERS/Jonathan Ernst

By Ahmed Aboulenein

WASHINGTON (Reuters) – U.S. President Joe Biden will unveil a new strategy for dealing with drug addiction and overdoses on Thursday that aims to expand access to medications for opioid overdoses, increase funding for law enforcement, and expand sanctions against traffickers.

The Biden administration is keen to show it is taking action on a worsening U.S. opioid crisis, which fueled more than an estimated 106,854 drug overdose deaths in the year to November 2021, a 15.6% increase from the same period a year earlier, according to U.S. Centers for Disease Control and Prevention data.

“That’s an American life lost every five minutes around the clock,” said Dr. Rahul Gupta, director of National Drug Control Policy at the White House.

“For too many years, the overdose crisis has been unraveling the very social fabric of our nation and destroying American lives and livelihoods,” Gupta told reporters on a press call.

The National Drug Control Strategy, which Biden will send to Congress on Thursday, seeks to double treatment admissions for populations that are most at risk of overdose deaths and ensure universal access to medications for opioid use disorder by 2025.

Currently, key tools like naloxone, a medication that can reverse opioid overdoses, and syringe service programs are often restricted or underfunded. There are legal barriers limiting access to naloxone in some states, and even in others the drug is not always available to those most at risk of an overdose.

Patients are more likely to receive a naloxone prescription if they had a prior diagnosis of opioid misuse or dependence along with an overdose compared with individuals who had those diagnoses without an overdose.

The administration also aims to triple the number of drug traffickers it sanctions and increase border security, said Gupta. Biden in December signed two executive orders aimed at fighting drug trafficking and criminal networks.

One order allowed for new sanctions on Chinese companies trading ingredients of the opioid drug fentanyl and on criminal gangs in Brazil, Mexico and Colombia.

Biden to unveil new U.S. drug addiction and overdose strategy

Join Our Time-Limited Free Subscription! Get Latest Trading Ideas, Business Info and Market Stocks.

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

You May Also Like


2/2 (C) Reuters. FILE PHOTO: Federal Reserve Chair Jerome Powell attends the House Financial Services Committee hearing on Capitol Hill in Washington, U.S., September...


Politics31 minutes ago (Oct 28, 2021 03:12PM ET) 2/2 (C) Reuters. FILE PHOTO: U.S. President Joe Biden delivers remarks on his Build Back Better...


Sign In/Free Sign Up 0 Stock Markets6 hours ago (Nov 22, 2021 07:52AM ET) (C) Reuters. By Peter Nurse — Stocks in focus...


4/4 (C) Reuters. FILE PHOTO: Campaign signs for Democrat Terry McAuliffe and Republican Glenn Youngkin stand together on the last day of early voting...


6/6 (C) Reuters. Smoke and flames rise over during the shelling near Kyiv, as Russia continues its invasion of Ukraine February 26, 2022. REUTERS/Gleb...


3/3 (C) Reuters. FILE PHOTO: Dmytro Dovzhenko, a Ukrainian veteran and military medical instructor, speaks during an interview with Reuters at his home in...

Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.

The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

© Copyright 2022, All Rights Reserved